Ophthalmology Activities

Exploring Novel and Emerging Therapies for the Management of Neovascular Age-Related Macular Degeneration: Assessing Clinical and Economic Barriers

0290-0000-21-121-L01-P

This live activity will present real-world data surrounding experience and outcomes with anti-VEGF agents in the treatment of neovascular AMD as well as clinical data updates for potential agents currently under investigation.

5-27-2021

1.00

Clinical Management of Allergic Conjunctivitis: Integrating Recommendations to Improve Treatment Outcomes

0290-0000-21-067-H01-P

This activity features video vignettes that illustrate counseling interactions between a patient and a pharmacist to provide a clear understanding about recommending over-the-counter treatment options for patients.

2.00

Clinical Management of Allergic Conjunctivitis: Integrating Recommendations to Improve Treatment Outcomes

0290-0000-21-067-H01-T

This technician activity features video vignettes that illustrate counseling interactions between a patient and a pharmacist to provide a clear understanding about recommending over-the-counter treatment options for patients.

2.00

Real-World Data on Neovascular Age-Related Macular Degeneration: Preserving Vision Acuity While Decreasing Injection Burden of Anti-VEGF Treatments

0290-0000-20-324-H01-P

This activity will focus on the appropriate consideration of emerging therapies to treat neovascular AMD, factors that contribute to decreasing the disease burden, and use of best practices in cost management.

1.50